If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Torben Plesner is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Osteoclasts Medicine & Life Sciences
zoledronic acid Medicine & Life Sciences
Osteoblasts Medicine & Life Sciences
Prednisone Medicine & Life Sciences
Alkaline Phosphatase Medicine & Life Sciences
Osteogenesis Medicine & Life Sciences
Melphalan Medicine & Life Sciences
Idiopathic Thrombocytopenic Purpura Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1988 2019

Daratumumab for treatment of blastic plasmacytoid dendritic cell neoplasm A single-case report

Iversen, K. F., Holdgaard, P. C., Preiss, B., Nyvold, C. G. & Plesner, T., Sep 2019, In : Haematologica. 104, 9, p. e432-e433

Research output: Contribution to journalJournal articleResearchpeer-review

Daratumumab plus lenalidomide and dexamethasone for untreated Myeloma

MAIA Trial Investigators, 30. May 2019, In : New England Journal of Medicine. 380, 22, p. 2104-2115

Research output: Contribution to journalJournal articleResearchpeer-review

Control Groups
Confidence Intervals
Neutropenia
daratumumab
Lymphopenia

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study

Plesner, T., Arkenau, H. T., Gay, F., Minnema, M. C., Boccadoro, M., Moreau, P., Cavenagh, J., Perrot, A., Laubach, J. P., Krejcik, J., Ahmadi, T., de Boer, C., Chen, D., Chiu, C., Schecter, J. M. & Richardson, P. G., Aug 2019, In : British Journal of Haematology. 186, 3, p. e35-e39

Research output: Contribution to journalLetterResearchpeer-review

71 Downloads (Pure)

High-Parameter Mass Cytometry Evaluation of Relapsed/Refractory Multiple Myeloma Patients Treated with Daratumumab Demonstrates Immune Modulation as a Novel Mechanism of Action

Adams, H. C., Stevenaert, F., Krejcik, J., Van der Borght, K., Smets, T., Bald, J., Abraham, Y., Ceulemans, H., Chiu, C., Vanhoof, G., Usmani, S. Z., Plesner, T., Lonial, S., Nijhof, I., Lokhorst, H. M., Mutis, T., van de Donk, N. W. C. J., Sasser, A. K. & Casneuf, T., 1. Mar 2019, In : Cytometry. Part A. 95, 3, p. 279-289

Research output: Contribution to journalJournal articleResearchpeer-review

Open Access
File
Granzymes
Flow Cytometry
Population
Immunophenotyping
Plasma Cells

Subcutaneous Delivery of Daratumumab in Relapsed or Refractory Multiple Myeloma

Usmani, S. Z., Nahi, H., Mateos, M-V., van de Donk, N. W. C. J., Chari, A., Kaufman, J. L., Moreau, P., Oriol, A., Plesner, T., Benboubker, L., Hellemans, P., Masterson, T., Clemens, P. L., Luo, M., Liu, K. & San Miguel, J., 22. Aug 2019, In : Blood. 134, 8, p. 668-677

Research output: Contribution to journalJournal articleResearchpeer-review

Hyaluronoglucosaminidase
Pharmacokinetics
Enzymes
daratumumab
Safety

Activities 2007 2019

DSMG plenummøde

Torben Plesner (Participant)
6. Nov 2019

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

11th European Myeloma Network

Torben Plesner (Participant)
29. Sep 201930. Sep 2019

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

17th International Myeloma Workshop

Torben Plesner (Participant)
12. Sep 201915. Sep 2019

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

NMSG-møde

Torben Plesner (Participant)
5. Sep 20196. Sep 2019

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

Controversies in Multiple Myeloma (COMy)

Torben Plesner (Participant)
16. May 201918. May 2019

Activity: Attending an eventOrganisation or participation in workshops, courses or seminars

Prizes

Ekstern bevilling: Oncopeptides kr. 50.000

Torben Plesner (Recipient), 2013

Prize: Prizes, scholarships, distinctions

Ekstern bevilling: Celgene kr. 428.987

Torben Plesner (Recipient), 2013

Prize: Prizes, scholarships, distinctions

Ekstern bevilling: Genmab kr. 834.855

Torben Plesner (Recipient), 2013

Prize: Prizes, scholarships, distinctions

Ekstern bevilling: Roche kr. 254.017

Torben Plesner (Recipient), 2013

Prize: Prizes, scholarships, distinctions

Ekstern bevilling: BMS kr. 464.022

Torben Plesner (Recipient), 2013

Prize: Prizes, scholarships, distinctions